Literature DB >> 25026357

Salvia miltiorrhiza compounds protect the liver from acute injury by regulation of p38 and NFκB signaling in Kupffer cells.

Shuqiang Yue1, Bin Hu, Zhipeng Wang, Zhenggang Yue, Fang Wang, Yuan Zhao, Zhifu Yang, Min Shen.   

Abstract

CONTEXT: Salvia miltiorrhiza Bunge is a traditional Asian medicine used to treat cerebral and cardiac ischemia. However, the effects of the active compounds of S. miltiorrhiza on liver damage are unclear.
OBJECTIVE: In this study, we tested the effects on acute liver injury of crude S. miltiorrhiza extracts from roots as well as neotanshinone B, dehydromiltirone, tanshinol A, tanshinone I, dihydrotanshinono I, neotanshinone A, cryptanshinono, tanshinone II A, and salvianolie acid B from purified S. miltiorrhiza extracts.
MATERIALS AND METHODS: Various compounds or ethanol extract of S. miltiorrhiza (50, 100, and 200 mg/kg, p.o.) were administered to rats for five consecutive days. After acute carbon tetrachloride (CCl4)-induced liver injury by treatment of rats with a single dose of CCl4 (0.75 mL/kg, p.o), rat liver function was tested by measuring serum biochemical parameters. Serum cytokine concentrations were assessed by enzyme-linked immunosorbent assay (ELISA). Expression of p38 and NFκB was evaluated by western blot.
RESULTS: All S. miltiorrhiza components showed their effects on liver function from the dose from 50 to 200 mg/kg. At the dose of 200 mg/kg, they reduced serum levels of alkaline phosphatase (ALP) by 34-77%, alanine aminotransferase (ALT) by 30-57%, aspartate aminotransferase (AST) by 43-72%, creatine total bilirubin (BIL-T) by 33-81%, albumin (ALB) by 37-67%, indicating that S. miltiorrhiza extracts protected liver from CCl4-induced damage. Moreover, S. miltiorrhiza extracts at 200 mg/kg reduced the increase in the proinflammatory cytokines tumor necrosis factor-α (TNF-α) by 25-82%, interleukin-1 (IL-1) by 42-74% and interleukin-6 (IL-6) by 67-83%, indicating an effect on alleviating liver inflammation. Furthermore, in vitro, S. miltiorrhiza extracts inhibited p38 and NFκB signaling in Kupffer cells. This effect could be a main mechanism by which S. miltiorrhiza protects against acute liver toxicity. DISCUSSION AND
CONCLUSION: Active compounds of S. miltiorrhiza protected the liver from CCl4-induced injury. Protection might have been due to inhibition of p38 and NFκB signaling in Kupffer cells, which subsequently reduced inflammation in the liver.

Entities:  

Keywords:  Inflammation; interleukin; nuclear factor kappa B; tumor necrosis factor

Mesh:

Substances:

Year:  2014        PMID: 25026357     DOI: 10.3109/13880209.2014.889720

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  9 in total

1.  Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice.

Authors:  Haifeng Teng; Meng Chen; Ansheng Zou; Haili Jiang; Jichun Han; Long Sun; Chao Feng; Ju Liu
Journal:  Iran J Basic Med Sci       Date:  2016-08       Impact factor: 2.699

2.  A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.

Authors:  Ming Hong; Sha Li; Ning Wang; Hor-Yue Tan; Fan Cheung; Yibin Feng
Journal:  Int J Mol Sci       Date:  2017-03-13       Impact factor: 5.923

Review 3.  Natural products that target macrophages in treating non-alcoholic steatohepatitis.

Authors:  Chun-Lin Li; Wen-Jun Zhou; Guang Ji; Li Zhang
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

4.  Molecular mechanism of the anti-inflammatory effects of Sophorae Flavescentis Aiton identified by network pharmacology.

Authors:  Naiqiang Zhu; Jingyi Hou
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity.

Authors:  Wei Deng; YanBo Huang; HaiShang Li; ChiWei Chen; YueWei Lin; Min Wang; HuaSheng Huang; Teng Liu; QiuLi Qin; Yang Shao; YongChao Tang; Kai Yuan; JinYong Ding; LiangLiang Xu; YongXian Li; ShunCong Zhang
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

6.  A systematic review and meta-analysis of treatment for hepatorenal syndrome with traditional Chinese medicine.

Authors:  Tingxue Song; Xiaozhong Guo; Lichun Shao; Mingyu Sun; Fernando Gomes Romeiro; Dan Han; Wenchun Bao; Xingshun Qi
Journal:  Transl Gastroenterol Hepatol       Date:  2018-08-22

Review 7.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

Review 8.  Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview.

Authors:  Alex Boye; Yan Yang; James Asenso; Wei Wei
Journal:  J Intercult Ethnopharmacol       Date:  2016-06-14

9.  Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components.

Authors:  Sha Li; Ning Wang; Ming Hong; Hor-Yue Tan; Guofeng Pan; Yibin Feng
Journal:  Molecules       Date:  2018-02-07       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.